PDCD1 and central nervous system cancer: This activity of GPNMB could explain our in vivo observation, namely the reduced levels of Foxp3+ T regs and PD-1+ T cells in the glioma tissue combined with increased levels of cytotoxic cells, CD8+ cells and proliferating T cells.